{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:07:38Z","timestamp":1770286058824,"version":"3.49.0"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09692-9","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T02:32:10Z","timestamp":1759545130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The invisible agitators: exploring the viral interplay in psoriatic immune dysregulation"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5955-7890","authenticated-orcid":false,"given":"Snehasis","family":"Nayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Budhera Nithika","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri Vaibhav","family":"Kintali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"issue":"1","key":"9692_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5958\/2231-5659.2019.00005.5","volume":"9","author":"R Unissa","year":"2019","unstructured":"Unissa R, Kumar PM, Pasha M, Begum S, Maheswari B. Psoriasis: a comprehensive review. Asian journal of Research in pharmaceutical science. 2019;9(1):29\u201338.","journal-title":"Asian journal of Research in pharmaceutical science"},{"issue":"15","key":"9692_CR2","doi-asserted-by":"publisher","first-page":"1308822","DOI":"10.3389\/fendo.2024.1308822","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Dong S, Ma Y, Mou Y. Burden of psoriasis in young adults worldwide from the global burden of disease study 2019. Front Endocrinol. 2024Feb;13(15):1308822.","journal-title":"Front Endocrinol"},{"issue":"8","key":"9692_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CE. Psoriasis prevalence in adults in the United States. JAMA Dermatol. 2021Aug 1;157(8):940\u20136.","journal-title":"JAMA Dermatol"},{"key":"9692_CR4","doi-asserted-by":"crossref","unstructured":"Pan R, Zhang J. Epidemiology and treatment of psoriasis: a Chinese perspective. Psoriasis: targets and therapy. 2014 Oct 13:37\u201347.","DOI":"10.2147\/PTT.S51717"},{"issue":"5","key":"9692_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715\u201325.","journal-title":"Immunity"},{"issue":"10","key":"9692_CR6","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.4049\/jimmunol.169.10.5673","volume":"169","author":"J Pirhonen","year":"2002","unstructured":"Pirhonen J, Matikainen S, Julkunen I. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol. 2002Nov 15;169(10):5673\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"9692_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","volume":"27","author":"BS McKenzie","year":"2006","unstructured":"McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23\u2013IL-17 immune pathway. Trends Immunol. 2006Jan 1;27(1):17\u201323.","journal-title":"Trends Immunol"},{"issue":"2","key":"9692_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","volume":"135","author":"C Tang","year":"2012","unstructured":"Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135(2):112\u201324. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03522.x.","journal-title":"Immunology"},{"issue":"11","key":"9692_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078091","volume":"8","author":"I Hus","year":"2013","unstructured":"Hus I, Bojarska-Junak A, Chocholska S, Tomczak W, Wo\u015b J, Dmoszy\u0144ska A, et al. Th-17\/IL-17A might play a protective role in chronic lymphocytic leukemia immunity. PLoS ONE. 2013Nov 1;8(11):e78091.","journal-title":"PLoS ONE"},{"issue":"1","key":"9692_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429","volume":"19","author":"JM de Morales","year":"2020","unstructured":"de Morales JM, Puig L, Daud\u00e9n E, Ca\u00f1ete JD, Pablos JL, Mart\u00edn AO, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmun Rev. 2020Jan 1;19(1):102429.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"9692_CR11","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/art.22866","volume":"56","author":"Z Chen","year":"2007","unstructured":"Chen Z, Tato CM, Muul L, Laurence A, O\u2019Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2007;56(9):2936\u201346.","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"9","key":"9692_CR12","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17\u2013producing helper T cells. Nat Immunol. 2007;8(9):950\u20137.","journal-title":"Nat Immunol"},{"issue":"6","key":"9692_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/ni.1610","volume":"9","author":"N Manel","year":"2008","unstructured":"Manel N, Unutmaz D, Littman DR. The differentiation of human TH-17 cells requires transforming growth factor-\u03b2 and induction of the nuclear receptor ROR\u03b3t. Nat Immunol. 2008;9(6):641\u20139.","journal-title":"Nat Immunol"},{"issue":"6","key":"9692_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","volume":"9","author":"E Volpe","year":"2008","unstructured":"Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hup\u00e9 P, Barillot E, et al. A critical function for transforming growth factor-\u03b2, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol. 2008;9(6):650\u20137.","journal-title":"Nat Immunol"},{"issue":"3","key":"9692_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/eji.200839066","volume":"39","author":"R Spolski","year":"2009","unstructured":"Spolski R, Leonard WJ. Cytokine mediators of Th-17 function. Eur J Immunol. 2009;39(3):658\u201361. https:\/\/doi.org\/10.1002\/eji.200839066.","journal-title":"Eur J Immunol"},{"key":"9692_CR16","doi-asserted-by":"crossref","unstructured":"Sundrud MS, Trivigno C. Identity crisis of Th-17 cells: many forms, many functions, many questions. InSeminars in immunology 2013 Nov 15 (Vol. 25, No. 4, pp. 263\u2013272). Academic Press","DOI":"10.1016\/j.smim.2013.10.021"},{"issue":"144","key":"9692_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.ai.2019.09.003","volume":"1","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Wang X, Dong C. Molecular mechanisms of T helper 17 cell differentiation: emerging roles for transcription cofactors. Adv Immunol. 2019Jan;1(144):121\u201353.","journal-title":"Adv Immunol"},{"issue":"64","key":"9692_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"1","author":"JL Harden","year":"2015","unstructured":"Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review. J Autoimmun. 2015Nov;1(64):66\u201373.","journal-title":"J Autoimmun"},{"issue":"5S","key":"9692_CR19","first-page":"18","volume":"102","author":"EB Lee","year":"2018","unstructured":"Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018Nov 1;102(5S):18\u201320.","journal-title":"Cutis"},{"issue":"4","key":"9692_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bjd.16083","volume":"178","author":"L Chen","year":"2018","unstructured":"Chen L, Tsai TF. HLA-Cw6 and psoriasis. Br J Dermatol. 2018Apr 1;178(4):854\u201362.","journal-title":"Br J Dermatol"},{"issue":"5","key":"9692_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1517\/14728222.2014.889686","volume":"18","author":"A Chiricozzi","year":"2014","unstructured":"Chiricozzi A, Saraceno R, Chimenti MS, Guttman-Yassky E, Krueger JG. Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target? Expert Opin Ther Targets. 2014May 1;18(5):513\u201325.","journal-title":"Expert Opin Ther Targets"},{"issue":"19","key":"9692_CR22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020May 19;323(19):1945\u201360.","journal-title":"JAMA"},{"issue":"1","key":"9692_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-\u03b1 production. J Exp Med. 2005Jul 4;202(1):135\u201343.","journal-title":"J Exp Med"},{"issue":"1","key":"9692_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20080129","volume":"206","author":"C Albanesi","year":"2009","unstructured":"Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med. 2009;206(1):249\u201358.","journal-title":"J Exp Med"},{"issue":"9","key":"9692_CR25","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1084\/jem.20090480","volume":"206","author":"D Ganguly","year":"2009","unstructured":"Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al. Self-RNA\u2013antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009Aug 31;206(9):1983\u201394.","journal-title":"J Exp Med"},{"issue":"1","key":"9692_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jid.2016.09.035","volume":"137","author":"T Mabuchi","year":"2017","unstructured":"Mabuchi T, Hwang ST. ACKR2: nature\u2019s decoy receptor lures unsuspecting chemokines in psoriasis. J Investig Dermatol. 2017Jan 1;137(1):7\u201311.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"9692_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004Aug 1;21(2):241\u201354.","journal-title":"Immunity"},{"issue":"6","key":"9692_CR28","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","volume":"174","author":"K Boniface","year":"2005","unstructured":"Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005Mar 15;174(6):3695\u2013702.","journal-title":"J Immunol"},{"issue":"3","key":"9692_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1346-8138.2011.01458.x","volume":"39","author":"K Nakajima","year":"2012","unstructured":"Nakajima K. Critical role of the interleukin-23\/\/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol. 2012;39(3):219\u201324.","journal-title":"J Dermatol"},{"issue":"10","key":"9692_CR30","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3390\/cells10102636","volume":"10","author":"L Mercurio","year":"2021","unstructured":"Mercurio L, Morelli M, Scarponi C, Scaglione GL, Pallotta S, Albanesi C, et al. PI3K\u03b4 sustains keratinocyte hyperproliferation and epithelial inflammation: implications for a topically druggable target in psoriasis. Cells. 2021Oct 2;10(10):2636.","journal-title":"Cells"},{"key":"9692_CR31","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/sj.jid.5700874","volume":"127","author":"C Rosenberger","year":"2007","unstructured":"Rosenberger C, Solovan C, Rosenberger AD, Jinping L, Treudler R, Frei U, et al. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol. 2007;127:2445\u201352.","journal-title":"J Invest Dermatol"},{"key":"9692_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/bjd.12271","volume":"169","author":"C Buerger","year":"2013","unstructured":"Buerger C, Malisiewicz B, Eiser A, Hardt K, Boehncke WH. Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin. Br J Dermatol. 2013;169:156\u20139.","journal-title":"Br J Dermatol"},{"key":"9692_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2340\/00015555-1737","volume":"94","author":"T Huang","year":"2014","unstructured":"Huang T, Lin X, Meng X, Lin M. Phosphoinositide-3 kinase\/protein kinase-B\/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target? Acta Derm Venereol. 2014;94:371\u20139.","journal-title":"Acta Derm Venereol"},{"key":"9692_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"D Antonella","year":"2009","unstructured":"Antonella D, Paola D, Frank O. The IL-23\/Th-17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129:1339\u201341.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9692_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1365-2133.2002.05009.x","volume":"147","author":"L Campbell","year":"2002","unstructured":"Campbell L, Laidler P, Watson RE, Kirby B, Griffiths CE, Gumbleton M. Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis. Br J Dermatol. 2002Oct 1;147(4):701\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"9692_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/exd.14068","volume":"29","author":"AN Egger","year":"2020","unstructured":"Egger AN, Rajabi-Estarabadi A, Williams NM, Resnik SR, Fox JD, Wong LL, et al. The importance of caveolins and caveolae to dermatology: lessons from the caves and beyond. Exp Dermatol. 2020;29(2):136\u201348.","journal-title":"Exp Dermatol"},{"issue":"6","key":"9692_CR37","first-page":"361","volume":"50","author":"L Campbell","year":"2000","unstructured":"Campbell L, Gumbleton M. Aberrant caveolin-1 expression in psoriasis: a signalling hypothesis. IUBMB Life. 2000;50(6):361\u20134.","journal-title":"IUBMB Life"},{"issue":"5","key":"9692_CR38","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1177\/030006051204000513","volume":"40","author":"WY Ma","year":"2012","unstructured":"Ma WY, Zhuang L, Cai DX, Zhong H, Zhao C, Sun Q. Inverse correlation between caveolin-1 expression and clinical severity in psoriasis vulgaris. J Int Med Res. 2012;40(5):1745\u201351.","journal-title":"J Int Med Res"},{"issue":"3","key":"9692_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/0019-5154.131374","volume":"59","author":"F Zhang","year":"2014","unstructured":"Zhang F, Li H, Zhou Y, Gu Y, Wang L. Caveolin-1 expression in different types of psoriatic lesions: analysis of 66 cases. Indian J Dermatol. 2014May 1;59(3):225\u20139.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"9692_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jdermsci.2022.07.003","volume":"107","author":"M Asami","year":"2022","unstructured":"Asami M, Ototake Y, Takamura N, Watanabe Y, Aihara M, Yamaguchi Y. Abnormal inflammatory traits and downregulated caveolin-1 expression in monocytes of psoriasis patients may be associated with psoriatic inflammation and atherosclerosis. J Dermatol Sci. 2022Aug 1;107(2):65\u201374.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"9692_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2024.100265","volume":"4","author":"DA Lin","year":"2024","unstructured":"Lin DA, Abujamra BA, Revah S, Nattkemper L, Morrison B, Romanelli P, et al. Downregulation of caveolae-associated proteins in psoriasis: a case series study. JID innovations. 2024Mar 1;4(2):100265.","journal-title":"JID innovations"},{"key":"9692_CR42","doi-asserted-by":"crossref","unstructured":"Kruglikov IL, Scherer PE. Caveolin-1 as a pathophysiological factor and target in psoriasis. npj Aging and Mechanisms of Disease. 2019 Feb 5;5(1):4.","DOI":"10.1038\/s41514-019-0034-x"},{"issue":"11","key":"9692_CR43","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/jid.2015.249","volume":"135","author":"Y Yamaguchi","year":"2015","unstructured":"Yamaguchi Y, Watanabe Y, Watanabe T, Komitsu N, Aihara M. Decreased expression of caveolin-1 contributes to the pathogenesis of psoriasiform dermatitis in mice. J Investig Dermatol. 2015Nov 1;135(11):2764\u201374.","journal-title":"J Investig Dermatol"},{"issue":"5","key":"9692_CR44","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3390\/ijms25052756","volume":"25","author":"H Kim","year":"2024","unstructured":"Kim H, Choi MR, Jeon SH, Jang Y, Yang YD. Pathophysiological roles of ion channels in epidermal cells, immune cells, and sensory neurons in psoriasis. Int J Mol Sci. 2024Feb 27;25(5):2756.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9692_CR45","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","volume":"138","author":"LA Nattkemper","year":"2018","unstructured":"Nattkemper LA, Tey HL, Valdes-Rodriguez R, Lee H, Mollanazar NK, Albornoz C, et al. The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Investig Dermatol. 2018Jun 1;138(6):1311\u20137.","journal-title":"J Investig Dermatol"},{"issue":"7","key":"9692_CR46","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1111\/jcmm.14392","volume":"23","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Han D, Follansbee T, Wu X, Yu S, Wang B, et al. Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice. J Cell Mol Med. 2019Jul;23(7):4819\u201328.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"9692_CR47","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jid.2023.05.009","volume":"143","author":"SN Amalia","year":"2023","unstructured":"Amalia SN, Baral H, Fujiwara C, Uchiyama A, Inoue Y, Yamazaki S, et al. TRPV4 regulates the development of psoriasis by controlling adenosine triphosphate expression in keratinocytes and the neuroimmune system. J Investig Dermatol. 2023Dec 1;143(12):2356\u201365.","journal-title":"J Investig Dermatol"},{"issue":"17","key":"9692_CR48","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1101\/gad.1686208","volume":"22","author":"T Grigoryan","year":"2008","unstructured":"Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008;22(17):2308\u201341.","journal-title":"Genes Dev"},{"issue":"1","key":"9692_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/stem.2723","volume":"36","author":"A Veltri","year":"2018","unstructured":"Veltri A, Lang C, Lien WH. Concise review: Wnt signaling pathways in skin development and epidermal stem cells. Stem Cells. 2018;36(1):22\u201335.","journal-title":"Stem Cells"},{"issue":"7","key":"9692_CR50","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/jid.2010.67","volume":"130","author":"JE Gudjonsson","year":"2010","unstructured":"Gudjonsson JE, Johnston A, Stoll SW, Riblett MB, Xing X, Kochkodan JJ, et al. Evidence for altered wnt signaling in psoriatic skin. J Invest Dermatol. 2010;130(7):1849\u201359 (Jul 1;).","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9692_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14209","volume":"33","author":"G Gupta","year":"2020","unstructured":"Gupta G, Singh Y, Tiwari J, Raizaday A, Alharbi KS, Al-Abbasi FA, et al. Beta-catenin non-canonical pathway: a potential target for inflammatory and hyperproliferative state via expression of transglutaminase 2 in psoriatic skin keratinocyte. Dermatol Ther. 2020;33(6):e14209.","journal-title":"Dermatol Ther"},{"issue":"1","key":"9692_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.jid.5700488","volume":"127","author":"J Reischl","year":"2007","unstructured":"Reischl J, Schwenke S, Beekman JM, Mrowietz U, St\u00fcrzebecher S, Heubach JF. Increased expression of Wnt5a in psoriatic plaques. J Investig Dermatol. 2007Jan 1;127(1):163\u20139.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"9692_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005354","volume":"4","author":"M Romanowska","year":"2009","unstructured":"Romanowska M, Evans A, Kellock D, Bray SE, McLean K, Donandt S, et al. Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon. PLoS ONE. 2009;4(4):e5354.","journal-title":"PLoS ONE"},{"issue":"5","key":"9692_CR54","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1159\/000430158","volume":"36","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Tu C, Zhang D, Zheng Y, Peng Z, Feng Y, et al. Wnt\/\u03b2-Catenin and Wnt5a\/Ca2+ pathways regulate proliferation and apoptosis of keratinocytes in psoriasis lesions. Cell Physiol Biochem. 2015Jul 1;36(5):1890\u2013902.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"9692_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5021\/ad.2016.28.1.45","volume":"28","author":"JE Kim","year":"2016","unstructured":"Kim JE, Bang SH, Choi JH, Kim CD, Won CH, Lee MW, et al. Interaction of Wnt5a with Notch1 is critical for the pathogenesis of psoriasis. Ann Dermatol. 2016Feb 1;28(1):45\u201354.","journal-title":"Ann Dermatol"},{"issue":"23","key":"9692_CR56","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.genrep.2021.101114","volume":"1","author":"EA Mohamed","year":"2021","unstructured":"Mohamed EA, Atef LM, Ibrahim GH, Toraih EA, Kamel N, Gomaa AH. Expression pattern of WNT5A among Egyptian patients with psoriasis treated with platelet-rich plasma versus conventional therapy: toward a better understanding of the disease. Gene Rep. 2021;1(23):101114.","journal-title":"Gene Rep"},{"issue":"12","key":"9692_CR57","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/exd.12539","volume":"23","author":"X Zhu","year":"2014","unstructured":"Zhu X, Wu Y, Huang S, Chen Y, Tao Y, Wang Y, et al. Overexpression of Wnt5a in mouse epidermis causes no psoriasis phenotype but an impairment of hair follicle anagen development. Exp Dermatol. 2014Dec;23(12):926\u20138.","journal-title":"Exp Dermatol"},{"key":"9692_CR58","doi-asserted-by":"crossref","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/\u03b2-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Molecular and cellular biology. 2002 Feb 1.","DOI":"10.1128\/MCB.22.4.1172-1183.2002"},{"key":"9692_CR59","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/00002030-199709000-00005","volume":"11","author":"SA Klein","year":"1997","unstructured":"Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS. 1997;11:1111\u20138.","journal-title":"AIDS"},{"issue":"11","key":"9692_CR60","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1258\/ijsa.2011.010525","volume":"22","author":"S Fernandes","year":"2011","unstructured":"Fernandes S, Pinto GM, Cardoso J. Particular clinical presentations of psoriasis in HIV patients. Int J STD AIDS. 2011;22(11):653\u20134.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"9692_CR61","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1111\/dth.12806","volume":"32","author":"M Ceccarelli","year":"2019","unstructured":"Ceccarelli M, Venanzi Rullo E, Vaccaro M, Facciol\u00e0 A, d\u2019Aleo F, Paolucci IA, et al. HIV-associated psoriasis: epidemiology, pathogenesis, and management. Dermatol Ther. 2019;32(2):e12806.","journal-title":"Dermatol Ther"},{"issue":"6","key":"9692_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.9999","volume":"21","author":"Y Teng","year":"2021","unstructured":"Teng Y, Xie W, Tao X, Liu N, Yu Y, Huang Y, et al. Infection-provoked psoriasis: induced or aggravated. Exp Ther Med. 2021Jun 1;21(6):1\u20139.","journal-title":"Exp Ther Med"},{"issue":"6","key":"9692_CR63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","volume":"25","author":"W Lew","year":"2004","unstructured":"Lew W, Bowcock AM, Krueger JG. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u2018Type 1\u2019 inflammatory gene expression. Trends Immunol. 2004Jun 1;25(6):295\u2013305.","journal-title":"Trends Immunol"},{"key":"9692_CR64","doi-asserted-by":"crossref","unstructured":"Fife DJ, Waller JM, Jeffes EW, Koo JY. Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles. Dermatology Online Journal. 2007;13(2).","DOI":"10.5070\/D34SF63339"},{"issue":"7","key":"9692_CR65","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","volume":"10","author":"N Morar","year":"2010","unstructured":"Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis. 2010Jul 1;10(7):470\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"9692_CR66","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1172\/JCI117892","volume":"95","author":"M Roederer","year":"1995","unstructured":"Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Investig. 1995May 1;95(5):2061\u20136.","journal-title":"J Clin Investig"},{"issue":"5","key":"9692_CR67","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/COH.0000000000000086","volume":"9","author":"JC Mudd","year":"2014","unstructured":"Mudd JC, Lederman MM. CD8 T cell persistence in treated HIV infection. Curr Opin HIV AIDS. 2014Sep 1;9(5):500\u20135.","journal-title":"Curr Opin HIV AIDS"},{"key":"9692_CR68","doi-asserted-by":"crossref","unstructured":"Cao W, Mehraj V, Kaufmann DE, Li T, Routy JP. Elevation and persistence of CD8 T\u2010cells in HIV infection: the Achilles heel in the ART era. African Journal of Reproduction and Gynaecological Endoscopy. 2016 Jan 1;19(1).","DOI":"10.7448\/IAS.19.1.20697"},{"issue":"11","key":"9692_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014108","volume":"5","author":"G Piskin","year":"2010","unstructured":"Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, Teunissen MB. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE. 2010Nov 24;5(11):e14108.","journal-title":"PLoS ONE"},{"key":"9692_CR70","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/jid.2012.456","volume":"133","author":"D Hijnen","year":"2013","unstructured":"Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-\u03b3, IL-13, IL-17, and IL-22. J Invest Dermatol. 2013;133:973\u20139.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9692_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.64","volume":"1","author":"YY Zhang","year":"2021","unstructured":"Zhang YY, Lin YT, Wang L, Sun XW, Dang EL, Xue K, et al. CD8\u03b1\u03b1+ T cells exert a pro-inflammatory role in patients with psoriasis. Skin Health and Disease. 2021Dec;1(4):e64.","journal-title":"Skin Health and Disease"},{"key":"9692_CR72","first-page":"1","volume":"20","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The immunology of psoriasis\u2014current concepts in pathogenesis. Clin Rev Allergy Immunol. 2024Apr;20:1\u201328.","journal-title":"Clin Rev Allergy Immunol"},{"key":"9692_CR73","doi-asserted-by":"crossref","unstructured":"FUCHS D, HAUSEN A, REIBNEGGER G, WERNER ER, DIERICH MP, WACHTER H. Psoriasis, gamma-interferon, and the acquired immunodeficiency syndrome. Annals of Internal Medicine. 1987 Jan 1;106(1):165-.","DOI":"10.7326\/0003-4819-106-1-165_2"},{"issue":"5","key":"9692_CR74","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1111\/1523-1747.ep12505743","volume":"95","author":"M Duvic","year":"1990","unstructured":"Duvic M. Immunology of AIDS related to psoriasis. J Investig Dermatol. 1990Nov 1;95(5):S38-40.","journal-title":"J Investig Dermatol"},{"issue":"11","key":"9692_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186823","volume":"12","author":"JR Fernandes","year":"2017","unstructured":"Fernandes JR, Berthoud TK, Kumar A, Angel JB. IL-23 signaling in Th-17 cells is inhibited by HIV infection and is not restored by HAART: implications for persistent immune activation. PLoS ONE. 2017Nov 1;12(11):e0186823.","journal-title":"PLoS ONE"},{"issue":"8","key":"9692_CR76","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","volume":"23","author":"KK Vidya Vijayan","year":"2017","unstructured":"Vidya Vijayan KK, Karthigeyan KP, Tripathi SP, Hanna LE. Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections. Front Immunol. 2017May;23(8):580.","journal-title":"Front Immunol"},{"issue":"3","key":"9692_CR77","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1365-2133.1998.02495.x","volume":"139","author":"E Mallon","year":"1998","unstructured":"Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R, et al. HLA-Cw\u229b 0602 and HIV-associated psoriasis. Br J Dermatol. 1998Sep 1;139(3):527\u201333.","journal-title":"Br J Dermatol"},{"issue":"13","key":"9692_CR78","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.3390\/ijms23136955","volume":"23","author":"S Zhou","year":"2022","unstructured":"Zhou S, Yao Z. Roles of infection in psoriasis. Int J Mol Sci. 2022Jun 23;23(13):6955.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9692_CR79","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/vaccines8030517","volume":"8","author":"B Pahar","year":"2020","unstructured":"Pahar B, Madonna S, Das A, Albanesi C, Girolomoni G. Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections. Vaccines. 2020Sep 10;8(3):517.","journal-title":"Vaccines"},{"issue":"6","key":"9692_CR80","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.peptides.2011.04.017","volume":"32","author":"JH Wong","year":"2011","unstructured":"Wong JH, Legowska A, Rolka K, Ng TB, Hui M, Cho CH, et al. Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides. 2011Jun 1;32(6):1117\u201322.","journal-title":"Peptides"},{"issue":"1","key":"9692_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.chom.2012.12.002","volume":"13","author":"Y Ogawa","year":"2013","unstructured":"Ogawa Y, Kawamura T, Matsuzawa T, Aoki R, Gee P, Yamashita A, et al. Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe. 2013Jan 16;13(1):77\u201386.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"9692_CR82","first-page":"1","volume":"12","author":"BL Bartlett","year":"2007","unstructured":"Bartlett BL, Khambaty M, Mendoza N, Tremaine AM, Gewirtzman A, Tyring SK. Dermatological management of human immunodeficiency virus (HIV). Skin Therapy Letter. 2007Oct 1;12(8):1\u20133.","journal-title":"Skin Therapy Letter"},{"issue":"7","key":"9692_CR83","first-page":"557","volume":"10","author":"S Vano-Galvan","year":"2008","unstructured":"Vano-Galvan S, Jaen P. Severe psoriasis due to cessation of antiretroviral therapy in a patient with human immunodeficiency virus. Isr Med Assoc J. 2008Jul 1;10(7):557\u20138.","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"9692_CR84","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000345762","volume":"225","author":"A Chiricozzi","year":"2013","unstructured":"Chiricozzi A, Saraceno R, Cannizzaro MV, Nistic\u00f2 SP, Chimenti S, Giunta A. Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir). Dermatology. 2013;225(4):333\u20137 (Mar 1;).","journal-title":"Dermatology"},{"issue":"5","key":"9692_CR85","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s13555-022-00722-0","volume":"12","author":"KA Papp","year":"2022","unstructured":"Papp KA, Beecker J, Cooper C, Kirchhof MG, Pozniak AL, Rockstroh JK, et al. Use of systemic therapies for treatment of psoriasis in people living with controlled HIV: inference-based guidance from a multidisciplinary expert panel. Dermatol Ther. 2022;12(5):1073\u201389.","journal-title":"Dermatol Ther"},{"issue":"7","key":"9692_CR86","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/aid.2013.0279","volume":"30","author":"V Tangpricha","year":"2014","unstructured":"Tangpricha V, Judd SE, Ziegler TR, Hao L, Alvarez JA, Fitzpatrick AM, et al. LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adults. AIDS Res Hum Retroviruses. 2014Jul 1;30(7):670\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"9692_CR87","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1099\/jmm.0.070888-0","volume":"63","author":"JR Honda","year":"2014","unstructured":"Honda JR, Connick E, MaWhinney S, Chan ED, Flores SC. Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy. J Med Microbiol. 2014;63(7):997\u20131003.","journal-title":"J Med Microbiol"},{"issue":"1","key":"9692_CR88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0889-857X(21)00088-0","volume":"17","author":"FC Arnett","year":"1991","unstructured":"Arnett FC, Reveille JD, Duvic M. Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am. 1991Feb;17(1):59\u201378.","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"9692_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/108729100317696","volume":"14","author":"E Mallon","year":"2000","unstructured":"Mallon E, Bunker CB. HIV-associated psoriasis. AIDS Patient Care STDS. 2000;14(5):239\u201346.","journal-title":"AIDS Patient Care STDS"},{"issue":"16","key":"9692_CR90","doi-asserted-by":"publisher","first-page":"27569","DOI":"10.18632\/oncotarget.15174","volume":"8","author":"E Clark","year":"2017","unstructured":"Clark E, Nava B, Caputi M. Tat is a multifunctional viral protein that modulates cellular gene expression and functions. Oncotarget. 2017Apr 4;8(16):27569.","journal-title":"Oncotarget"},{"issue":"17","key":"9692_CR91","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1128\/JVI.02869-15","volume":"90","author":"A Christensen-Quick","year":"2016","unstructured":"Christensen-Quick A, Lafferty M, Sun L, Marchionni L, DeVico A, Garzino-Demo A. Human Th-17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection. J Virol. 2016Sep 1;90(17):7833\u201347.","journal-title":"J Virol"},{"issue":"91","key":"9692_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107331","volume":"1","author":"PS Aghbash","year":"2021","unstructured":"Aghbash PS, Hemmat N, Nahand JS, Shamekh A, Memar MY, Babaei A, et al. The role of Th-17 cells in viral infections. Int Immunopharmacol. 2021Feb;1(91):107331.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"9692_CR93","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1189\/jlb.4A0516-216R","volume":"101","author":"YY Mitsuki","year":"2017","unstructured":"Mitsuki YY, Tuen M, Hioe CE. Differential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+ CD4+ T cells. J Leukoc Biol. 2017;101(1):339\u201350.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"9692_CR94","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.190109","volume":"9","author":"WT Ma","year":"2019","unstructured":"Ma WT, Yao XT, Peng Q, Chen DK. The protective and pathogenic roles of IL-17 in viral infections: friend or foe? Open Biol. 2019Jul 24;9(7):190109.","journal-title":"Open Biol"},{"issue":"2","key":"9692_CR95","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-0714.1992.tb00980.x","volume":"21","author":"A Langford","year":"1992","unstructured":"Langford A, Kunze R, Lobeck H, Pohle HD, Reichart P. Distribution of cytokeratins in oral cytological smears of HIV-infected patients. J Oral Pathol Med. 1992;21(2):58\u201364.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"9692_CR96","first-page":"29","volume":"8","author":"B Sebok","year":"1998","unstructured":"Sebok B, Bonnekoh B, Vetter R, Schneider I, Gollnick H, Mahrle G. The antipsoriatic dimethyl-fumarate suppresses interferon-gamma -induced ICAM-1 and HLA-DR expression on hyperproliferative keratinocytes. Quantification by a culture plate-directed APAAP-ELISA technique. Eur J Dermatol. 1998;8(1):29\u201332.","journal-title":"Eur J Dermatol"},{"issue":"12","key":"9692_CR97","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1001\/archderm.1988.01670120051010","volume":"124","author":"BJ Nickoloff","year":"1988","unstructured":"Nickoloff BJ. Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. Arch Dermatol. 1988;124(12):1835.","journal-title":"Arch Dermatol"},{"issue":"4","key":"9692_CR98","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0190-9622(89)70073-6","volume":"20","author":"CE Griffiths","year":"1989","unstructured":"Griffiths CE, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol. 1989Apr;20(4):617\u201329.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"9692_CR99","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2133.1992.tb00647.x","volume":"126","author":"JN Barker","year":"1992","unstructured":"Barker JN, MacDonald DM. Cutaneous lymphocyte trafficking in the inflammatory dermatoses. Br J Dermatol. 1992;126(3):211\u20135.","journal-title":"Br J Dermatol"},{"issue":"4","key":"9692_CR100","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2353\/ajpath.2008.070710","volume":"172","author":"SP Raychaudhuri","year":"2008","unstructured":"Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol. 2008Apr 1;172(4):961\u201371.","journal-title":"Am J Pathol"},{"issue":"3","key":"9692_CR101","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/ije\/dyaa027","volume":"49","author":"ML Chen","year":"2020","unstructured":"Chen ML, Kao WM, Huang JY, Hung YM, Wei JC. Human papillomavirus infection associated with increased risk of new-onset psoriasis: a nationwide population-based cohort study. Int J Epidemiol. 2020Jun 1;49(3):786\u201397.","journal-title":"Int J Epidemiol"},{"key":"9692_CR102","doi-asserted-by":"crossref","unstructured":"FARAG AG, ELSHAYB EE, AL SHARAKY DR, ELASHAFEY EN, KHADRA AA. Role of HCV infection in psoriasis: a clinical and immunohistochemical study. Journal of Clinical & Diagnostic Research. 2019 May 1;13(5).","DOI":"10.7860\/JCDR\/2019\/39627.12833"},{"key":"9692_CR103","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/1346-8138.12112","volume":"40","author":"S Imafuku","year":"2013","unstructured":"Imafuku S, Nakayama J. Profile of patients with psoriasis associated with hepatitis C virus infection. J Dermatol. 2013;40:428\u201333.","journal-title":"J Dermatol"},{"issue":"9","key":"9692_CR104","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/archdermatol.2012.1401","volume":"148","author":"RS Azfar","year":"2012","unstructured":"Azfar RS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM. Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol. 2012Sep 1;148(9):995\u20131000.","journal-title":"Arch Dermatol"},{"issue":"1","key":"9692_CR105","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013Jan 1;149(1):84\u201391.","journal-title":"JAMA Dermatol"},{"issue":"18","key":"9692_CR106","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.3390\/jcm12185814","volume":"12","author":"B Grygiel-G\u00f3rniak","year":"2023","unstructured":"Grygiel-G\u00f3rniak B, Skoczek W. Molecular background and clinical implications of glucose disorders in patients with psoriatic arthritis. J Clin Med. 2023Sep 7;12(18):5814.","journal-title":"J Clin Med"},{"issue":"1","key":"9692_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/qjmed\/hci001","volume":"98","author":"H Knobler","year":"2005","unstructured":"Knobler H, Schattner A. TNF-\u03b1, chronic hepatitis C and diabetes: a novel triad. QJM. 2005Jan 1;98(1):1\u20136.","journal-title":"QJM"},{"issue":"2","key":"9692_CR108","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4254\/wjh.v8.i2.131","volume":"8","author":"H Knobler","year":"2016","unstructured":"Knobler H, Malnick S. Hepatitis C and insulin action: an intimate relationship. World J Hepatol. 2016Jan 1;8(2):131.","journal-title":"World J Hepatol"},{"issue":"6","key":"9692_CR109","first-page":"1384","volume":"38","author":"S Aytug","year":"2003","unstructured":"Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1\/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology. 2003Dec 1;38(6):1384\u201392.","journal-title":"Hepatology"},{"issue":"8","key":"9692_CR110","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1136\/gut.2010.228262","volume":"60","author":"M Eslam","year":"2011","unstructured":"Eslam M, Khattab MA, Harrison SA. Insulin resistance and hepatitis C: an evolving story. Gut. 2011Aug 1;60(8):1139\u201351.","journal-title":"Gut"},{"issue":"4","key":"9692_CR111","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/jdv.13578","volume":"31","author":"K Chun","year":"2017","unstructured":"Chun K, Afshar M, Audish D, Kabigting F, Paik A, Gallo R, et al. Hepatitis C may enhance key amplifiers of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(4):672\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"110","key":"9692_CR112","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/0074-02760140309","volume":"31","author":"JL Trujillo-Ochoa","year":"2015","unstructured":"Trujillo-Ochoa JL, Corral-Jara KF, Escobedo-Mel\u00e9ndez G, Realpe M, Panduro A, Roman S, et al. T-helper 17-related cytokines and IgE antibodies during hepatitis A virus infection in children. Mem Inst Oswaldo Cruz. 2015Mar;31(110):263\u20136.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9692_CR113","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10620-011-1997-z","volume":"57","author":"RG Foster","year":"2012","unstructured":"Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR. Interleukin (IL)-17\/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection. Dig Dis Sci. 2012;57:381\u20139.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"9692_CR114","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1440-1746.2011.06782.x","volume":"27","author":"Q Chang","year":"2012","unstructured":"Chang Q, Wang YK, Zhao Q, Wang CZ, Hu YZ, Wu BY. Th-17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2012;27(2):273\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"9692_CR115","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/imm.12330","volume":"143","author":"C Hao","year":"2014","unstructured":"Hao C, Zhou Y, He Y, Fan C, Sun L, Wei X, et al. Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C. Immunology. 2014;143(4):531\u20138.","journal-title":"Immunology"},{"issue":"7","key":"9692_CR116","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/ijms17071070","volume":"17","author":"P Meng","year":"2016","unstructured":"Meng P, Zhao S, Niu X, Fu N, Su S, Wang R, et al. Involvement of the interleukin-23\/interleukin-17 axis in chronic hepatitis C virus infection and its treatment responses. Int J Mol Sci. 2016Jul 15;17(7):1070.","journal-title":"Int J Mol Sci"},{"key":"9692_CR117","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00430-017-0527-9","volume":"207","author":"R Baharlou","year":"2018","unstructured":"Baharlou R, Romani B, Kiani SJ, Sadeghi K, Shadmand E, Fazel H, et al. Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients. Med Microbiol Immunol. 2018;207:65\u201374.","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"9692_CR118","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-3083.2012.04582.x","volume":"27","author":"M Afshar","year":"2013","unstructured":"Afshar M, Martinez AD, Gallo RL, Hata TR. Induction and exacerbation of psoriasis with interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases. J Eur Acad Dermatol Venereol. 2013;27(6):771\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"9692_CR119","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdcr.2018.11.016","volume":"5","author":"Y Koike","year":"2019","unstructured":"Koike Y, Fujiki Y, Higuchi M, Fukuchi R, Kuwatsuka S, Murota H. An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis. JAAD Case Reports. 2019Feb 1;5(2):150\u20132.","journal-title":"JAAD Case Reports"},{"key":"9692_CR120","doi-asserted-by":"crossref","unstructured":"Duncan JR, Orlowski TJ, Elewski BE. Safety of guselkumab in hepatitis B virus infection. Dermatology Online Journal. 2019;25(10).","DOI":"10.5070\/D32510045827"},{"issue":"1","key":"9692_CR121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdcr.2020.12.006","volume":"8","author":"EJ Song","year":"2021","unstructured":"Song EJ, Whitman P, Samsel J. The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infection. JAAD Case Rep. 2021;8(1):37\u20139.","journal-title":"JAAD Case Rep"},{"issue":"30","key":"9692_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdcr.2022.09.023","volume":"1","author":"PY Chen","year":"2022","unstructured":"Chen PY, Farrer S, Miranda-Cacdac L, Song EJ. The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: a case series. JAAD Case Reports. 2022Dec;1(30):1\u20134.","journal-title":"JAAD Case Reports"},{"key":"9692_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-021-01606-z","volume":"18","author":"Y Liu","year":"2021","unstructured":"Liu Y, Cui SN, Duan MY, Dou ZL, Li YZ, Liu YX, et al. Is there a relationship between psoriasis and hepatitis C? A meta-analysis and bioinformatics investigation. Virol J. 2021;18:1\u20130.","journal-title":"Virol J"},{"key":"9692_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-015-0232-y","volume":"13","author":"L Vargiu","year":"2016","unstructured":"Vargiu L, Rodriguez-Tom\u00e9 P, Sperber GO, Cadeddu M, Grandi N, Blikstad V, et al. Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology. 2016;13:1\u201329.","journal-title":"Retrovirology"},{"issue":"3","key":"9692_CR125","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41580-023-00674-z","volume":"25","author":"N Dopkins","year":"2024","unstructured":"Dopkins N, Nixon DF. Activation of human endogenous retroviruses and its physiological consequences. Nat Rev Mol Cell Biol. 2024;25(3):212\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"9692_CR126","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/jid.2011.217","volume":"131","author":"ME Ariza","year":"2011","unstructured":"Ariza ME, Williams MV. A human endogenous retrovirus K dUTPase triggers a TH1, TH-17 cytokine response: does it have a role in psoriasis? J Investig Dermatol. 2011Dec 1;131(12):2419\u201327.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"9692_CR127","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2133.2005.06555.x","volume":"153","author":"JP Mol\u00e8s","year":"2005","unstructured":"Mol\u00e8s JP, Tesniere A, Guilhou JJ. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Br J Dermatol. 2005;153(1):83\u20139.","journal-title":"Br J Dermatol"},{"key":"9692_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-3-44","volume":"3","author":"C Nellaker","year":"2006","unstructured":"Nellaker C, Yao Y, Jones-Brando L, et al. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology. 2006;3:44.","journal-title":"Retrovirology"},{"key":"9692_CR129","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/13550280600614973","volume":"12","author":"K Ruprecht","year":"2006","unstructured":"Ruprecht K, Obojes K, Wengel V, et al. Regulation of human endogenous retrovirus W protein expression by herpes sim plex virus type 1: implications for multiple sclerosis. J Neurovirol. 2006;12:65\u201371.","journal-title":"J Neurovirol"},{"issue":"1","key":"9692_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02592.x","volume":"138","author":"PN Nelson","year":"2004","unstructured":"Nelson PN, Hooley P, Roden D, Davari Ejtehadi H, Rylance P, Warren P, et al. Human endogenous retroviruses: transposable elements with potential? Clin Exp Immunol. 2004Oct;138(1):1\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"9692_CR131","first-page":"313","volume":"28","author":"A Larek-R\u0105pa\u0142a","year":"2011","unstructured":"Larek-R\u0105pa\u0142a A, \u017baba R, Kowalczyk MJ, Szramka-Pawlak B, Schwartz RA. Herpes simplex virus infection as a possible modulator of autoimmune diseases facilitated by human endogenous retroviruses. Advances in Dermatology and Allergology\/Post\u0119py Dermatologii i Alergologii. 2011;28(4):313\u20136.","journal-title":"Advances in Dermatology and Allergology\/Post\u0119py Dermatologii i Alergologii"},{"key":"9692_CR132","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1172\/JCI111678","volume":"75","author":"AL Cunningham","year":"1985","unstructured":"Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest. 1985;75:226\u201333.","journal-title":"J Clin Invest"},{"issue":"3","key":"9692_CR133","doi-asserted-by":"publisher","first-page":"394","DOI":"10.37349\/ei.2024.00148","volume":"4","author":"A Mukhopadhyay","year":"2024","unstructured":"Mukhopadhyay A, Indra S, Ghosh J, Biswas S, Palit P, Chattopadhyay D. Herpes simplex virus-mediated skin infections: cytokines and its interplay. Exploration of Immunology. 2024Jun 30;4(3):394\u2013413.","journal-title":"Exploration of Immunology"},{"key":"9692_CR134","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yadr.2008.09.004","volume":"24","author":"LS Miller","year":"2008","unstructured":"Miller LS. Toll-like receptors in skin. Adv Dermatol. 2008;24:71.","journal-title":"Adv Dermatol"},{"issue":"10","key":"9692_CR135","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","volume":"136","author":"L Senra","year":"2016","unstructured":"Senra L, et al. Keratinocyte-derived IL-17E contributes to inflammation in psoriasis. J Invest Dermatol. 2016;136(10):1970\u201380.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9692_CR136","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.immuni.2018.03.019","volume":"48","author":"M Xu","year":"2018","unstructured":"Xu M, Lu H, Lee YH, Wu Y, Liu K, Shi Y, et al. An interleukin-25-mediated autoregulatory circuit in keratinocytes plays a pivotal role in psoriatic skin inflammation. Immunity. 2018Apr 17;48(4):787\u201398.","journal-title":"Immunity"},{"issue":"12","key":"9692_CR137","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1038\/jid.2013.223","volume":"133","author":"BE Kim","year":"2013","unstructured":"Kim BE, Bin L, Ye YM, Ramamoorthy P, Leung DY. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Investig Dermatol. 2013Dec 1;133(12):2678\u201385.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"9692_CR138","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/2229-5178.79863","volume":"2","author":"M George","year":"2011","unstructured":"George M, Pakran J, Rajan U, George S, Thomas S. Localized psoriasis herpeticum: case report and review of literature. Indian Dermatol Online J. 2011Jan 1;2(1):16.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"9692_CR139","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaad.2005.01.140","volume":"53","author":"BR Santmyire-Rosenberger","year":"2005","unstructured":"Santmyire-Rosenberger BR, Nigra TP. Psoriasis herpeticum: three cases of Kaposi\u2019s varicelliform eruption in psoriasis. J Am Acad Dermatol. 2005Jul 1;53(1):52\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"9692_CR140","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0019-5154.96197","volume":"57","author":"G Garg","year":"2012","unstructured":"Garg G, Thami GP. Psoriasis herpeticum due to Varicella zoster virus: a Kaposi\u2019s varicelliform eruption in erythrodermic psoriasis. Indian J Dermatol. 2012May 1;57(3):213\u20134.","journal-title":"Indian J Dermatol"},{"issue":"8","key":"9692_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179447","volume":"12","author":"SY Tsai","year":"2017","unstructured":"Tsai SY, Chen HJ, Lio CF, Ho HP, Kuo CF, Jia X, et al. Increased risk of herpes zoster in patients with psoriasis: a population-based retrospective cohort study. PLoS ONE. 2017Aug 22;12(8):e0179447.","journal-title":"PLoS ONE"},{"issue":"8","key":"9692_CR142","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.jid.2018.01.039","volume":"138","author":"J Takeshita","year":"2018","unstructured":"Takeshita J, Shin DB, Ogdie A, Gelfand JM. Risk of serious infection, opportunistic infection, and herpes zoster among patients with psoriasis in the United Kingdom. J Investig Dermatol. 2018Aug 1;138(8):1726\u201335.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"9692_CR143","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ajd.13534","volume":"62","author":"C Min","year":"2021","unstructured":"Min C, Yoo DM, Kim M, Choi HG. Increased risk of herpes zoster in patients with psoriasis: a longitudinal follow-up study using a national sample cohort. Australas J Dermatol. 2021;62(2):183\u20139.","journal-title":"Australas J Dermatol"},{"issue":"11","key":"9692_CR144","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s13555-023-00988-y","volume":"13","author":"D Singer","year":"2023","unstructured":"Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, et al. Burden of herpes zoster among patients with psoriasis in the United States. Dermatology and Therapy. 2023Nov;13(11):2649\u201368.","journal-title":"Dermatology and Therapy"},{"issue":"1","key":"9692_CR145","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ajd.13945","volume":"64","author":"YW Chen","year":"2023","unstructured":"Chen YW, Shen A, Wang YH, Wei JC, Yeh CJ. Increased risk of psoriasis: an immune sequela of herpes zoster? Evidence from a nationwide population-based cohort study. Australas J Dermatol. 2023Feb;64(1):92\u20139.","journal-title":"Australas J Dermatol"},{"issue":"9","key":"9692_CR146","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1468-3083.2011.04230.x","volume":"26","author":"J Dreiher","year":"2012","unstructured":"Dreiher J, Kresch FS, Comaneshter D, Cohen AD. Risk of herpes zoster in patients with psoriasis treated with biologic drugs. J Eur Acad Dermatol Venereol. 2012;26(9):1127\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"9692_CR147","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/jdv.12307","volume":"28","author":"L Adelzadeh","year":"2014","unstructured":"Adelzadeh L, Jourabchi N, Wu JJ. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions. J Eur Acad Dermatol Venereol. 2014Jul;28(7):846\u201352.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"9692_CR148","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamadermatol.2014.4956","volume":"151","author":"G Shalom","year":"2015","unstructured":"Shalom G, Zisman D, Bitterman H, Harman-Boehm I, Greenberg-Dotan S, Dreiher J, et al. Systemic therapy for psoriasis and the risk of herpes zoster: a 500 000 person-year study. JAMA Dermatol. 2015May 1;151(5):533\u20138.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"9692_CR149","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaad.2017.03.023","volume":"77","author":"KL Winthrop","year":"2017","unstructured":"Winthrop KL, Lebwohl M, Cohen AD, Weinberg JM, Tyring SK, Rottinghaus ST, et al. Herpes zoster in psoriasis patients treated with tofacitinib. J Am Acad Dermatol. 2017Aug 1;77(2):302\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"9692_CR150","doi-asserted-by":"crossref","unstructured":"Shalom G, Naldi L, Lebwohl M, Nikkels A, de Jong EM, Fakharzadeh S, Goyal KG, Srivastava B, Langholff W, Galindo C, Cohen AD. Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of Dermatological Treatment. 2019 Jun 6.","DOI":"10.1080\/09546634.2018.1445193"},{"key":"9692_CR151","doi-asserted-by":"crossref","unstructured":"Ji YZ, Liu SR. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Bioscience reports. 2019 Dec;39(12): BSR20193266.","DOI":"10.1042\/BSR20193266"},{"key":"9692_CR152","unstructured":"Sanchez DP, Sonthalia S. Koebner phenomenon. InStatPearls [Internet] 2022 Nov 14. StatPearls Publishing."},{"issue":"1","key":"9692_CR153","first-page":"70","volume":"61","author":"SK Bose","year":"1995","unstructured":"Bose SK. Probable mechanism of varicella-induced koebnerization in psoriasis. Indian J Dermatol Venereol Leprol. 1995Jan 1;61(1):70\u20131.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"9692_CR154","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1346-8138.2009.00767.x","volume":"37","author":"S Singh","year":"2010","unstructured":"Singh S, Singh S, Singh U. Induction of psoriasis and Koebner\u2019s phenomenon. J Dermatol. 2010Jun 1;37(6):568.","journal-title":"J Dermatol"},{"key":"9692_CR155","doi-asserted-by":"crossref","unstructured":"Sillen H, Maes M, Boiy T, Wojciechowski M. Plaque psoriasis following Kawasaki disease and varicella. Case Reports. 2018 Aug 3;2018: bcr-2018.","DOI":"10.1136\/bcr-2018-224539"},{"key":"9692_CR156","doi-asserted-by":"crossref","unstructured":"Posligua A, Maldonado C, Gonzalez-Gonzalez M. Rupioid psoriasis preceded by varicella presenting as Koebner phenomenon. In JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2016 May 1 (Vol. 74, No. 5, pp. AB268-AB268). 360 PARK AVENUE SOUTH, NEW YORK, NY 10010\u20131710 USA: MOSBY-ELSEVIER.","DOI":"10.1016\/j.jaad.2016.02.1036"},{"issue":"26","key":"9692_CR157","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001009","volume":"94","author":"YK Zhao","year":"2015","unstructured":"Zhao YK, Zhang YQ, Wang F, Wu HH, Luo ZY, Luo DQ, et al. Developing shingles-induced Koebner phenomenon in a patient with psoriasis: a case report. Medicine. 2015Jul 1;94(26):e1009.","journal-title":"Medicine"},{"key":"9692_CR158","doi-asserted-by":"crossref","unstructured":"Siauw LO, Teguh Y. Isomorphic (Koebner) and isotopic (Wolf\u2019s) phenomenon of post herpes zoster psoriasis: a compilation of case studies and narrative review. Cermin Dunia Kedokteran [Internet]. 2024 Oct. 4;51(10):596\u20139.","DOI":"10.55175\/cdk.v51i10.1065"},{"key":"9692_CR159","unstructured":"Kim HS, Jun HJ, Lee JD. Transient receptor potential vanilloid-1 (trpv1) in herpes zoster: its expression and potential significance. 2014;66(2):340-."},{"issue":"8","key":"9692_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.753819","volume":"4","author":"F Liviero","year":"2021","unstructured":"Liviero F, Campisi M, Mason P, Pavanello S. Transient receptor potential vanilloid subtype 1: potential role in infection, susceptibility, symptoms and treatment of COVID-19. Front Med. 2021Nov;4(8):753819.","journal-title":"Front Med"},{"key":"9692_CR161","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/JIR.S397079","volume":"31","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhao S, Xing X, Shang L, Cao J, He Y. Effects of neuropeptides on dendritic cells in the pathogenesis of psoriasis. J Inflamm Res. 2023Dec;31:35\u201343.","journal-title":"J Inflamm Res"},{"key":"9692_CR162","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF00506259","volume":"317","author":"F Erjavec","year":"1981","unstructured":"Erjavec F, Lembeck F, Florjanc-Irman T, Skofitsch G, Donnerer J, Saria A, et al. Release of histamine by substance P. Naunyn-Schmiedebergs Arch Pharmacol. 1981;317:67\u201370.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"9692_CR163","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0190-9622(86)70034-0","volume":"14","author":"EM Farber","year":"1986","unstructured":"Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol. 1986Feb 1;14(2):305\u201311.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9692_CR164","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-5728(99)00182-4","volume":"102","author":"I Marriott","year":"2000","unstructured":"Marriott I, Mason MJ, Elhofy A, Bost KL. Substance P activates NF-\u03baB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol. 2000Jan 24;102(2):163\u201371.","journal-title":"J Neuroimmunol"},{"key":"9692_CR165","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00371834","volume":"285","author":"A Naukkarinen","year":"1993","unstructured":"Naukkarinen A, Harvima I, Paukkonen K, Aalto ML, Horsmanheimo M. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res. 1993;285:341\u20136.","journal-title":"Arch Dermatol Res"},{"key":"9692_CR166","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00403-007-0745-x","volume":"299","author":"C Remr\u00f6d","year":"2007","unstructured":"Remr\u00f6d C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007;299:85\u201391.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"9692_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2012.11.418","volume":"69","author":"K Yoneda","year":"2013","unstructured":"Yoneda K, Matsuoka-Shirahige Y, Demitsu T, Kubota Y. Cytomegalovirus infection is one of the precipitating factors for pustular psoriasis. J Dermatol Sci. 2013Feb 1;69(2):e38.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"9692_CR168","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2133.1999.02926.x","volume":"141","author":"K Asadullah","year":"1999","unstructured":"Asadullah K, Pr\u00f6sch S, Audring H, B\u00fcttnerova I, Volk HD, Sterry W, et al. A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor \u03b1 overexpression. Br J Dermatol. 1999Jul 1;141(1):94\u2013102.","journal-title":"Br J Dermatol"},{"issue":"7","key":"9692_CR169","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1600-0625.2011.01250.x","volume":"20","author":"M Weitz","year":"2011","unstructured":"Weitz M, Kiessling C, Friedrich M, Pr\u00f6sch S, H\u00f6flich C, Kern F, et al. Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis. Exp Dermatol. 2011Jul;20(7):561\u20137.","journal-title":"Exp Dermatol"},{"issue":"6","key":"9692_CR170","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/000155500300012738","volume":"80","author":"B Kirby","year":"2000","unstructured":"Kirby B, Al-Jiffri O, Cooper RJ, Corbitt G, Klapper PE, Griffiths CE. Investigation of cytomegalovirus and human herpes viruses 6 and 7 as possible causative antigens in psoriasis. Acta Derm Venereol. 2000Nov 1;80(6):404\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"9692_CR171","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/bjd.13026","volume":"171","author":"FR Ali","year":"2014","unstructured":"Ali FR, Green R, McMullen E, Motta L, Judge MR. Cutaneous cytomegalovirus complicating pustular psoriasis. Br J Dermatol. 2014Sep 1;171(3):670\u20131.","journal-title":"Br J Dermatol"},{"issue":"11","key":"9692_CR172","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1099\/0022-1317-74-11-2333","volume":"74","author":"J Stein","year":"1993","unstructured":"Stein J, Volk HD, Liebenthal C, Kr\u00fcger DH, Pr\u00f6sch S. Tumour necrosis factor \u03b1 stimulates the activity of the human cytomegalovirus major immediate early enhancer\/promoter in immature monocytic cells. J Gen Virol. 1993;74(11):2333\u20138.","journal-title":"J Gen Virol"},{"issue":"8892","key":"9692_CR173","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(94)91116-9","volume":"343","author":"WD D\u00f6cke","year":"1994","unstructured":"D\u00f6cke WD, Fietze E, Syrbe U, von Baehr R, Volk HD, Pr\u00f6sch S, et al. Cytomegalovirus reactivation and tumour necrosis factor. The Lancet. 1994Jan 29;343(8892):268\u20139.","journal-title":"The Lancet"},{"issue":"5","key":"9692_CR174","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01560-18","volume":"9","author":"E Forte","year":"2018","unstructured":"Forte E, Swaminathan S, Schroeder MW, Kim JY, Terhune SS, Hummel M. Tumor necrosis factor alpha induces reactivation of human cytomegalovirus independently of myeloid cell differentiation following posttranscriptional establishment of latency. MBio. 2018Nov 7;9(5):10\u2013128.","journal-title":"MBio"},{"issue":"4","key":"9692_CR175","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1523-1747.1998.00164.x","volume":"110","author":"M Favre","year":"1998","unstructured":"Favre M, Orth G, Majewski S, Pura A, Jablonska S, Baloul S. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Investig Dermatol. 1998Apr 1;110(4):311\u20137.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"9692_CR176","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1046\/j.1523-1747.1999.00641.x","volume":"113","author":"SJ Weissenborn","year":"1999","unstructured":"Weissenborn SJ, Pfister HJ, Fuchs PG, H\u00f6pfl R, Weber F, Smola H. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Investig Dermatol. 1999Jul 1;113(1):122\u20136.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"9692_CR177","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1046\/j.1365-2133.2003.05587.x","volume":"149","author":"E Mahe","year":"2003","unstructured":"Mahe E, Bodemer C, Descamps V, Mahe I, Crickx B, De Prost Y, et al. High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Br J Dermatol. 2003Oct 1;149(4):819\u201325.","journal-title":"Br J Dermatol"},{"key":"9692_CR178","doi-asserted-by":"crossref","unstructured":"Handisurya A, L\u00e1z\u00e1r S, Papay P, Primas C, Haitel A, Horvat R, Tanew A, Vogelsang H, Kirnbauer R. Anogenital human papillomavirus prevalence is unaffected by therapeutic tumour necrosis factor-alpha inhibition. Acta Dermato-Venereologica. 2016 May 1;96(4).","DOI":"10.2340\/00015555-2298"},{"issue":"01","key":"9692_CR179","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/JD9.0000000000000224","volume":"7","author":"KP Lema-Matehu","year":"2024","unstructured":"Lema-Matehu KP, Lascano-Gallegos NP, Palacios-\u00c1lvarez SA. Human papillomavirus within psoriasis plaques in a patient with psoriasis: a case report. International Journal of Dermatology and Venereology. 2024Mar 30;7(01):55\u20137.","journal-title":"International Journal of Dermatology and Venereology"},{"issue":"3","key":"9692_CR180","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0304-3940(94)11195-O","volume":"184","author":"P Anand","year":"1995","unstructured":"Anand P, Foley P, Navsaria HA, Sinicropi D, Williams-Chestnut RE, Leigh IM. Nerve growth factor levels in cultured human skin cells: effect of gestation and viral transformation. Neurosci Lett. 1995Jan 30;184(3):157\u201360.","journal-title":"Neurosci Lett"},{"issue":"2","key":"9692_CR181","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/all.13322","volume":"73","author":"T Nakahara","year":"2018","unstructured":"Nakahara T, Kido-Nakahara M, Ohno F, Ulzii D, Chiba T, Tsuji G, et al. The pruritogenic mediator endothelin-1 shifts the dendritic cell\u2013T-cell response toward Th-17\/Th1 polarization. Allergy. 2018;73(2):511\u20135.","journal-title":"Allergy"},{"key":"9692_CR182","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.2147\/CCID.S402168","volume":"31","author":"CN da Silva","year":"2023","unstructured":"da Silva CN, Miot HA, Grassi TF, Dias-Mel\u00edcio LA, Santos L, Esp\u00f3sito AC. Expression of endothelin-1, endothelin receptor-A, and endothelin receptor-B in facial melasma compared to adjacent skin. Clin Cosmet Investig Dermatol. 2023Dec;31:2847\u201353.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"9692_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/rr44","volume":"2","author":"KA Fagan","year":"2001","unstructured":"Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res. 2001;2:1\u20132.","journal-title":"Respir Res"},{"key":"9692_CR184","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/354645","volume":"2010","author":"S Salvatore","year":"2010","unstructured":"Salvatore S, Vingolo EM. Endothelin-1 role in human eye: a review. J Ophthalmol. 2010;2010:2010(1):354645.","journal-title":"J Ophthalmol"},{"issue":"77","key":"9692_CR185","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/bs.apha.2016.05.002","volume":"1","author":"M Houde","year":"2016","unstructured":"Houde M, Desbiens L, D\u2019Orl\u00e9ans-Juste P. Endothelin-1: biosynthesis, signaling and vasoreactivity. Adv Pharmacol. 2016Jan;1(77):143\u201375.","journal-title":"Adv Pharmacol"},{"key":"9692_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-140","volume":"10","author":"A Venuti","year":"2011","unstructured":"Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, et al. Papillomavirus E5: the smallest oncoprotein with many functions. Mol Cancer. 2011;10:1\u20138.","journal-title":"Mol Cancer"},{"issue":"2","key":"9692_CR187","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.0906-6705.2005.00261.x","volume":"14","author":"D Kovacs","year":"2005","unstructured":"Kovacs D, Falchi M, Cardinali G, Raffa S, Carducci M, Cota C, et al. Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis. Exp Dermatol. 2005;14(2):130\u20137.","journal-title":"Exp Dermatol"},{"issue":"8","key":"9692_CR188","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1600-0625.2006.00450.x","volume":"15","author":"N Nagy","year":"2006","unstructured":"Nagy N, Bata-Cs\u00f6rg\u0151 Z, Kopasz N, Szeg C, Pivarcsi A, Koreck A, et al. The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes. Exp Dermatol. 2006Aug;15(8):596\u2013605.","journal-title":"Exp Dermatol"},{"issue":"6","key":"9692_CR189","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.0906-6705.2003.00125.x","volume":"12","author":"S Majewski","year":"2003","unstructured":"Majewski S, Jablonska S. Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: a proposed hypothesis. Exp Dermatol. 2003Dec;12(6):721\u20138.","journal-title":"Exp Dermatol"},{"issue":"4","key":"9692_CR190","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","volume":"26","author":"DE Ribeiro","year":"2021","unstructured":"Ribeiro DE, Oliveira-Giacomelli A, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry. 2021;26(4):1044\u201359.","journal-title":"Mol Psychiatry"},{"issue":"14","key":"9692_CR191","doi-asserted-by":"publisher","first-page":"1182454","DOI":"10.3389\/fimmu.2023.1182454","volume":"5","author":"V Vultaggio-Poma","year":"2023","unstructured":"Vultaggio-Poma V, Sanz JM, Amico A, Violi A, Ghisellini S, Pizzicotti S, et al. The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients. Front Immunol. 2023May;5(14):1182454.","journal-title":"Front Immunol"},{"issue":"10","key":"9692_CR192","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00109-024-02481-1","volume":"102","author":"BG de Carvalho","year":"2024","unstructured":"de Carvalho BG, Francisco GR, Bagatini MD. Current treatment of psoriasis triggered by cytokine storm and future immunomodulation strategies. J Mol Med. 2024Oct;102(10):1187\u201398.","journal-title":"J Mol Med"},{"key":"9692_CR193","doi-asserted-by":"crossref","unstructured":"Nigro P, Pompilio G, Capogrossi MC. Cyclophilin A: a key player for human disease. Cell death & disease. 2013 Oct;4(10):e888-.","DOI":"10.1038\/cddis.2013.410"},{"issue":"148","key":"9692_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103293","volume":"1","author":"W Yang","year":"2024","unstructured":"Yang W, Bai X, Jia X, Li H, Min J, Li H, et al. The binding of extracellular cyclophilin A to ACE2 and CD147 triggers psoriasis-like inflammation. J Autoimmun. 2024Sep;1(148):103293.","journal-title":"J Autoimmun"},{"issue":"8","key":"9692_CR195","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med. 2005;11(8):875\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"9692_CR196","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JVI.01248-09","volume":"84","author":"I Glowacka","year":"2010","unstructured":"Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, Muench MO, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010Jan 15;84(2):1198\u2013205.","journal-title":"J Virol"},{"key":"9692_CR197","doi-asserted-by":"crossref","unstructured":"Lu Y, Zhu Q, Fox DM, Gao C, Stanley SA, Luo K. SARS-CoV-2 down-regulates ACE2 through lysosomal degradation. Molecular Biology of the Cell. 2022 Dec 1;33(14):ar147.","DOI":"10.1091\/mbc.E22-02-0045"},{"issue":"1","key":"9692_CR198","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41392-023-01719-7","volume":"8","author":"X Sheng","year":"2023","unstructured":"Sheng X, Zhu F, Peng H, Yang F, Yang Y, Yang C, et al. Host cyclophilin A facilitates SARS-CoV-2 infection by binding and stabilizing spike on virions. Signal Transduct Target Ther. 2023Dec 14;8(1):459.","journal-title":"Signal Transduct Target Ther"},{"key":"9692_CR199","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00403-006-0678-9","volume":"298","author":"AC Yazici","year":"2006","unstructured":"Yazici AC, Aslan G, Baz K, Ikizoglu G, Api H, Serin MS, et al. A high prevalence of parvovirus B19 DNA in patients with psoriasis. Arch Dermatol Res. 2006;298:231\u20135.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"9692_CR200","first-page":"200","volume":"44","author":"M Yildirim","year":"2010","unstructured":"Yildirim M, Ceyhan AM, Aridogan BC, Koc IG, Kaya S. Investigation of relationship between parvovirus B19 infection and psoriasis\/Psoriasis ve parvovirus B19 enfeksiyonu arasindaki iliskinin arastirilmasi. Archives of the Turkish Dermatology and Venerology. 2010Dec 1;44(4):200\u20134.","journal-title":"Archives of the Turkish Dermatology and Venerology"},{"issue":"2","key":"9692_CR201","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jmv.2217","volume":"67","author":"LA Mitchell","year":"2002","unstructured":"Mitchell LA. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J Med Virol. 2002;67(2):267\u201374.","journal-title":"J Med Virol"},{"issue":"6","key":"9692_CR202","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1111\/ijd.14785","volume":"59","author":"KM Araujo","year":"2020","unstructured":"Araujo KM, Bressan AL, Azulay-Abulafia L. Zika, chikungunya, and dengue infections as exacerbating factors of psoriasis in patients receiving biological therapy. Int J Dermatol. 2020;59(6):e209\u201311.","journal-title":"Int J Dermatol"},{"issue":"10","key":"9692_CR203","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/j.1346-8138.2011.01200.x","volume":"38","author":"AS Kolalapudi","year":"2011","unstructured":"Kolalapudi AS, Kode SR. Chikungunya infection: a new trigger for psoriasis. J Dermatol. 2011Oct 1;38(10):1033\u20134.","journal-title":"J Dermatol"},{"issue":"5","key":"9692_CR204","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4103\/idoj.IDOJ_429_16","volume":"8","author":"R Kumar","year":"2017","unstructured":"Kumar R, Sharma MK, Jain SK, Yadav SK, Singhal AK. Cutaneous manifestations of chikungunya fever: observations from an outbreak at a Tertiary Care Hospital in Southeast Rajasthan. India Indian dermatology online journal. 2017Sep 1;8(5):336\u201342.","journal-title":"India Indian dermatology online journal"},{"issue":"2","key":"9692_CR205","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/ced.13294","volume":"43","author":"AE Paniz Mondolfi","year":"2018","unstructured":"Paniz Mondolfi AE, Hernandez Perez M, Blohm G, Marquez M, Mogollon Mendoza A, Hernandez-Pereira CE, et al. Generalized pustular psoriasis triggered by Zika virus infection. Clin Exp Dermatol. 2018Mar 1;43(2):171\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"9692_CR206","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00430-015-0445-7","volume":"205","author":"D Tappe","year":"2016","unstructured":"Tappe D, P\u00e9rez-Gir\u00f3n JV, Zammarchi L, Rissland J, Ferreira DF, Jaenisch T, et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med Microbiol Immunol. 2016;205:269\u201373.","journal-title":"Med Microbiol Immunol"},{"issue":"2","key":"9692_CR207","doi-asserted-by":"publisher","first-page":"e00289","DOI":"10.1128\/mbio.00289-22","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Poo YS, Alves JC, Almeida RP, Mostafavi H, Tang PC, et al. Interleukin-17 contributes to chikungunya virus-induced disease. MBio. 2022Apr 26;13(2):e00289-e322.","journal-title":"MBio"},{"issue":"1","key":"9692_CR208","first-page":"38","volume":"101","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Abrouk M, Farahnik B, Zhu TH, Bhutani T. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies. Cutis. 2018Jan 1;101(1):38.","journal-title":"Cutis"},{"issue":"4","key":"9692_CR209","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.adengl.2018.02.020","volume":"109","author":"N Queir\u00f3s","year":"2018","unstructured":"Queir\u00f3s N, Torres T. HIV-associated psoriasis. Actas Dermo-Sifiliogr\u00e1ficas (English Edition). 2018May 1;109(4):303\u201311.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"key":"9692_CR210","unstructured":"DermNet. Psoriasis \u2013 Guidelines for the management of psoriasis [Internet]. DermNet; [cited 2025 Jul 5]. Available from: https:\/\/dermnetnz.org\/topics\/guidelines-for-the-treatment-of-psoriasis"},{"issue":"4","key":"9692_CR211","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1204a179","volume":"12","author":"A Tsentemeidou","year":"2022","unstructured":"Tsentemeidou A, Sotiriou E, Sideris N, Bakirtzi K, Papadimitriou I, Lallas A, et al. Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature. Dermatology Practical & Conceptual. 2022Oct 1;12(4):e2022179.","journal-title":"Dermatology Practical & Conceptual"},{"issue":"2","key":"9692_CR212","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0190-9622(94)70175-X","volume":"31","author":"TA Maurer","year":"1994","unstructured":"Maurer TA, Zackheim HS, Tuffaneli L, Berger TG. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol. 1994Aug 1;31(2):372\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"9692_CR213","doi-asserted-by":"crossref","unstructured":"Bartos G, Cline A, Beroukhim K, Burrall BA, Feldman SR. Current biological therapies for use in HIV-positive patients with psoriasis: case report of guselkumab used and review. Dermatology Online Journal. 2018;24(11).","DOI":"10.5070\/D32411041999"},{"issue":"1","key":"9692_CR214","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/2475530320954279","volume":"6","author":"B Myers","year":"2021","unstructured":"Myers B, Thibodeaux Q, Reddy V, Chan S, Brownstone N, Liao W, et al. Biologic treatment of 4 HIV-positive patients: a case series and literature review. Journal of Psoriasis and Psoriatic Arthritis\u00ae. 2021;6(1):19\u201326.","journal-title":"Journal of Psoriasis and Psoriatic Arthritis\u00ae"},{"issue":"8","key":"9692_CR215","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/jdv.19020","volume":"37","author":"J Xu","year":"2023","unstructured":"Xu J, Gill K, Flora A, Kozera E, Frew JW. The impact of psoriasis biologic therapy on HIV viral load and CD4+ cell counts in HIV-positive individuals: a real-world cohort study. J Eur Acad Dermatol Venereol. 2023;37(8):1659\u201363.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"9692_CR216","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-0781.2010.00492.x","volume":"26","author":"SA Salem","year":"2010","unstructured":"Salem SA, Fakkar NM, Fathi G, El-Reheem SM, El-Tabakh AA, Ragab DM. Comparative study of human papilloma virus in untreated and ultraviolet-treated psoriatic patients. Photodermatol Photoimmunol Photomed. 2010Apr;26(2):78\u201382.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"9692_CR217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/jjm-153407","volume":"18","author":"L Ersoy","year":"2025","unstructured":"Ersoy L, Ulger ST, Yazici AC, Aslan G. Alpha human papillomavirus types and genotype distribution in psoriasis patients: a cross-sectional regional study in Turkey. Jundishapur J Microbiol. 2025;18(1):1\u20138.","journal-title":"Jundishapur J Microbiol"},{"issue":"3","key":"9692_CR218","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/archderm.140.3.317","volume":"140","author":"P Wolf","year":"2004","unstructured":"Wolf P, Seidl H, B\u00e4ck B, Binder B, H\u00f6fler G, Quehenberger F, et al. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen\u2013UV-A. Arch Dermatol. 2004Mar 1;140(3):317\u201324.","journal-title":"Arch Dermatol"},{"issue":"6","key":"9692_CR219","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1258\/ijsa.2011.011331","volume":"23","author":"YP Tian","year":"2012","unstructured":"Tian YP, Yao L, Malla P, Song Y, Li SS. Successful treatment of giant condyloma acuminatum with combination retinoid and interferon-\u03b3 therapy. Int J STD AIDS. 2012;23(6):445\u20137.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"9692_CR220","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14637","volume":"34","author":"M Oren-Shabtai","year":"2021","unstructured":"Oren-Shabtai M, Snast I, Noyman Y, Lapidoth M, Sherman S, Mimouni D, et al. Topical and systemic retinoids for the treatment of cutaneous viral warts: a systematic review and meta-analysis. Dermatol Ther. 2021;34(1):e14637.","journal-title":"Dermatol Ther"},{"issue":"1","key":"9692_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13555-012-0001-y","volume":"2","author":"BE Strober","year":"2012","unstructured":"Strober BE, Clay Cather J, Cohen D, Crowley JJ, Gordon KB, Gottlieb AB, et al. A Delphi consensus approach to challenging case scenarios in moderate-to-severe psoriasis: part 1. Dermatol Ther (Heidelb). 2012;2(1):1.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"9692_CR222","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000117709","volume":"216","author":"C Antoniou","year":"2008","unstructured":"Antoniou C, Kosmadaki MG, Stratigos AJ, Katsambas AD. Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy. Dermatology. 2008;216(4):364\u20135.","journal-title":"Dermatology"},{"issue":"10","key":"9692_CR223","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jdcr.2018.08.014","volume":"4","author":"ME Anderson","year":"2018","unstructured":"Anderson ME, Queen D, Vance SL, Geskin LJ. Ustekinumabassociated disseminated verrucae. JAAD Case Rep. 2018;4(10):1030\u20133.","journal-title":"JAAD Case Rep"},{"key":"9692_CR224","unstructured":"Augustin M, von Kiedrowsky R, Korber A, Mrowietz U, Reich K, Thaci D. Recommendations for systemic therapy in persons with psoriasis during the pandemic phase of SARS-COV-2 (corona virus). PsoNet; 2020. URL: psobesV. de\/wpcontent\/uploads\/2020\/03\/RundschreibenPsoBestPsoNetCoronafinale ngl. 1.1. pdf. 2020 Aug 3."},{"key":"9692_CR225","unstructured":"Psoriasis Association. COVID-19 Information [Internet][cited 2025 Jul 5]. Available from: https:\/\/www.psoriasis-association.org.uk\/covid-19-information"},{"issue":"9","key":"9692_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092422","volume":"11","author":"A Campanati","year":"2022","unstructured":"Campanati A, Diotallevi F, Martina E, Radi G, Offidani A. Treatment of moderate to severe psoriasis during the covid-19 pandemic: lessons learned and opportunities. J Clin Med. 2022;11(9):2422.","journal-title":"J Clin Med"},{"issue":"14","key":"9692_CR227","doi-asserted-by":"publisher","first-page":"1294056","DOI":"10.3389\/fmicb.2023.1294056","volume":"10","author":"Y Song","year":"2023","unstructured":"Song Y, Yao L, Li S, Zhou J. Psoriasis comorbidity management in the COVID era: a pressing challenge. Front Microbiol. 2023Nov;10(14):1294056.","journal-title":"Front Microbiol"},{"issue":"1","key":"9692_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54424-y","volume":"14","author":"Y Zou","year":"2024","unstructured":"Zou Y, Xu J, Chen AJ, Huang K, Zhu SM, Li JJ, et al. Prevalence, outcomes and associated factors of SARS-CoV-2 infection in psoriasis patients of Southwest China: a cross-sectional survey. Sci Rep. 2024;14(1):6331.","journal-title":"Sci Rep"},{"issue":"6","key":"9692_CR229","volume":"33","author":"\u00d6F Elmas","year":"2020","unstructured":"Elmas \u00d6F, Demirba\u015f A, Kutlu \u00d6, Ba\u011fc\u0131er F, Metin MS, \u00d6zyurt K, et al. Psoriasis and COVID-19: a narrative review with treatment considerations. Dermatol Ther. 2020Nov;33(6):e13858.","journal-title":"Dermatol Ther"},{"key":"9692_CR230","unstructured":"International Psoriasis Council. Revised Statement on COVID-19 [Internet]. St. Louis (MO): International Psoriasis Council; [cited 2025 Jul 5]. Available from: https:\/\/psoriasiscouncil.org\/covid-19\/revised-statement-covid-19\/"},{"issue":"3","key":"9692_CR231","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/TJD.TJD_42_20","volume":"14","author":"S \u00d6z\u00e7elik","year":"2020","unstructured":"\u00d6z\u00e7elik S, K\u0131l\u0131 FA. Hepatitis B virus reactivation in patients with psoriasis on biologic therapies: a retrospective study. Turk J Dermatol. 2020;14(3):65\u201370.","journal-title":"Turk J Dermatol"},{"issue":"6","key":"9692_CR232","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s12325-024-02873-2","volume":"41","author":"M Megna","year":"2024","unstructured":"Megna M, Lauletta G, Tommasino N, Salsano A, Battista T, Ruggiero A, et al. Management of psoriasis patients with serious infectious diseases. Adv Ther. 2024;41(6):2099\u2013111.","journal-title":"Adv Ther"},{"issue":"28","key":"9692_CR233","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.3748\/wjg.v22.i28.6444","volume":"22","author":"C Bonifati","year":"2016","unstructured":"Bonifati C, Lora V, Graceffa D, Nosotti L. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World J Gastroenterol. 2016Jul 28;22(28):6444.","journal-title":"World J Gastroenterol"},{"key":"9692_CR234","doi-asserted-by":"crossref","unstructured":"Mateu-Arrom L, Puig L. Infection risk and vaccination in the management of psoriasis: considerations for biologic therapy. Psoriasis: Targets and Therapy. 2025 Dec 31:127\u201344.","DOI":"10.2147\/PTT.S510141"},{"issue":"2","key":"9692_CR235","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast A, Smith C, Spuls PI, et al. Euroguiderm guideline on the systemic treatment of Psoriasis vulgaris\u2014part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35(2):281\u2013317.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"9692_CR236","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1111\/JDV.16683","volume":"34","author":"JLW Lambert","year":"2020","unstructured":"Lambert JLW, Segaert S, Ghislain PD, et al. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian evidence-based treatment advice in psoriasis; part 2). J Eur Acad Dermatol Venereol. 2020;34(9):1914\u201323. https:\/\/doi.org\/10.1111\/JDV.16683.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9692_CR237","doi-asserted-by":"crossref","unstructured":"Ch\u2019en PY, Farrer S, Miranda-Cacdac L, Song EJ. The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: a case series. JAAD Case Reports. 2022 Dec 1;30:1\u20134.","DOI":"10.1016\/j.jdcr.2022.09.023"},{"key":"9692_CR238","doi-asserted-by":"crossref","unstructured":"Ciolfi C, Balestri R, Bardazzi F, Burlando M, Chersi K, Costanzo A, Dapavo P, Gisondi P, Malagoli P, Pizzolato M, Rech G. Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: a multicentric retrospective cohort study of 49 patients. Journal of the European Academy of Dermatology & Venereology. 2023 Oct 1;37(10).","DOI":"10.1111\/jdv.19186"},{"key":"9692_CR239","doi-asserted-by":"crossref","unstructured":"Gargiulo L, Pavia G, Valenti M, Lleo de Nalda A, Perugini C, Costanzo A, Narcisi A. Safety of biologic therapies in patients with moderate-to-severe plaque psoriasis and concomitant viral hepatitis: a monocentric retrospective study. Dermatology and Therapy. 2022 May;12(5):1263\u201370.","DOI":"10.1007\/s13555-022-00726-w"},{"key":"9692_CR240","doi-asserted-by":"crossref","unstructured":"Frankel AJ, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF Jr., et al. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;61(6):1044\u201355.","DOI":"10.1016\/j.jaad.2009.03.044"},{"key":"9692_CR241","doi-asserted-by":"crossref","unstructured":"Zein NN, Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. Journal of hepatology. 2005 Mar 1;42(3):315\u201322.","DOI":"10.1016\/j.jhep.2004.11.025"},{"issue":"9","key":"9692_CR242","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.clinthera.2005.09.007","volume":"27","author":"RG Langley","year":"2005","unstructured":"Langley RG, Carey WP, Rafal ES, Tyring SK, Caro I, Wang X, et al. Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience. Clin Ther. 2005Sep 1;27(9):1317\u201328.","journal-title":"Clin Ther"},{"issue":"s2","key":"9692_CR243","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2133.2007.07764.x","volume":"156","author":"C Antoniou","year":"2007","unstructured":"Antoniou C, Stefanaki I, Stratigos A, Avgerinou G, Stavropoulos P, Potouridou I, et al. The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital. Br J Dermatol. 2007Apr 1;156(s2):12\u20136.","journal-title":"Br J Dermatol"},{"issue":"1","key":"9692_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91356-3","volume":"11","author":"SW Ting","year":"2021","unstructured":"Ting SW, Ting SY, Lin YS, Lin MS, Kuo G. Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study. Sci Rep. 2021;11(1):11824.","journal-title":"Sci Rep"},{"issue":"82","key":"9692_CR245","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4103\/0378-6323.183630","volume":"1","author":"M Megna","year":"2016","unstructured":"Megna M, Napolitano M, Ayala F, Balato N. The risk of herpes zoster in patients with psoriasis: a retrospective records-based observational study. Indian J Dermatol Venereol Leprol. 2016Nov;1(82):744.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"40","key":"9692_CR246","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027368","volume":"100","author":"A Zou","year":"2021","unstructured":"Zou A, Chen Y, Shi N, Ye Y. Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Medicine. 2021Oct 8;100(40):e27368.","journal-title":"Medicine"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09692-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09692-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09692-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:02:54Z","timestamp":1770235374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09692-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":246,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9692"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09692-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}